Associations of vitamin D receptor gene polymorphisms FokI and BsmI with susceptibility to rheumatoid arthritis and Behçet's disease in Tunisians

Joint Bone Spine

Volumn 79, Issue 2, 2012, Pages 144-148

  Karray, Emna Fakhfakh ^a,b   Ben Dhifallah, Imen ^a   Ben Abdelghani, Kawther ^b   Ben Ghorbel, Imed ^c   Khanfir, Monia ^c   Houman, Habib ^c   Hamzaoui, Kamel ^a   Zakraoui, Leith ^b  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b MONGI SLIM HOSPITAL   (Tunisia)

^c LA RABTA HOSPITAL   (Tunisia)

Author keywords

Beh et's disease; Gene polymorphism; Rheumatoid arthritis; Vitamin D receptor

Indexed keywords

BSMI PROTEIN; FOKI PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ADULT; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; TUNISIA;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARTHRITIS, RHEUMATOID; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; SEX CHARACTERISTICS; TUNISIA;

EID: 84857795319     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.06.003     Document Type: Article

References (35)

1. Singal D.P., Li J., Zhu Y. Genetic basis for rheumatoid arthritis. Arch Immunol. Ther Exp (Warsz) 1999, 47:307-311.
2. Brennan F., Beech J. Update on cytokines in rheumatoid arthritis. Curr Opin Rheumatol 2007, 19:296-301.
3. Morel J., Berenbaum F. Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint Bone Spine 2004, 71:503-510.
4. Combe B., Benessiano J., Berenbaum F., et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007, 74:440-445.
5. Chevessier F., Faraut B., Ravel-Chapuis A., et al. Towards the molecular elucidation of congenital myasthenic syndromes: identification of mutations in MuSK. Acta Myol 2005, 24:55-59.
6. McInnes I.B., Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7:429-442.
7. Falgarone G., Duclos M., Boissier M.C. TNFa antagonists in rheumatoid arthritis patients seen in everyday practice. Joint Bone Spine 2007, 74:523-526.
8. e partie traitement. Rev Med Suisse 2006, 2:1052-1057. [In French].
9. Imamura Y., Kurokawa M.S., Yoshikawa H., et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol 2005, 139:371-378.
10. Todaro M., Zerilli M., Triolo G., et al. NF-kappaB protects Behcet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins. Arthritis Rheum 2005, 52:2179-2191.
11. Garabedian M. La 1,25 dihydroxyvitamine D et son récepteur. Rev Rhum [Ed Fr] 2000, 67:39-41. [In French].
12. Choukri F., Chakib A., Himmich H., et al. HLA-B phenotype modifies the course of Behcet's disease in Moroccan patients. Tissue Antigens 2003, 61:92-96.
13. Malloy P.J., Pike J.W., Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25_dihydroxyvitamin D-resistant rickets. Endocrine Rev 1999, 20:156-188.
14. Morrison N.A., Yeoman R., Kelly P.J., et al. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc. Natl. Acad. Sci. U. S. A 1992, 89:6665-6669.
15. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
16. Prevoo M.L., van't Hof M.A., Kuper H.H., et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48.
17. Criteria for diagnosis of Behcxet's disease. Lancet 1990, 335:1078. International Study Group for Behcet's Disease.
18. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
19. Pani M.A., Knapp M., Donner H., et al. receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000, 49:5047.
20. Rass P., Pákozdi A., Lakatos P., et al. Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int 2006, 26:964-971.
21. Lee Y.H., Bae S.C., Choi S.J., et al. Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 2011, 38(6):3643-3651.
22. Maalej A., Petit-Teixeira E., Chabchoub G., et al. Lack of association of vdr gene polymorphisms with thyroid autoimmune disorders: familial and case/control studies. J Clin Immunol 2008, 28:21-25.
23. Maalej A., Petit-Teixeira E., Michou L., et al. Association study of VDR gene with rheumatoid arthritis in the French population. Genes Immun 2005, 6:707-711.
24. Sakulpipatsin W., Verasertniyom O., Nantiruj K., et al. Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus. Arthritis Res Ther 2006, 8:R48.
25. Lemos M.C., Fagulha A., Coutinho E., et al. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Human Immunol 2008, 69:134-138.
26. Lee Y.H., Woo J.H., Choi S.J., et al. Vitamin D receptor TaqI, BsmI and ApaI polymorphisms and osteoarthritis susceptibility: a meta-analysis. Joint Bone Spine 2009, 76:156-161.
27. Sian Beavan, Ann Prentice, Liya Yan, et al. Differences in vitamin D receptor genotype and geographical variation in osteoporosis. Lancet 1996, 348:136-137.
28. OzakiY, NomuraS, NagahamaM, et al. Vitamin D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus. Nephron 2000, 85:86-91.
29. Huang C.M., Wu M.C., Wu J.Y., et al. Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 2002, 11:31-34.
30. Morrison N.A., Qi J.C., Tokita A., et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367:284-287.
31. Decker C.J., Parker R. Diversity of cytoplasmic functions for the 3 untranslated region of eukaryotic transcripts. Curr Opin Cell Biol 1995, 7:386-392.
32. Denise B., Mory, Elo â.R., et al. Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to beta-cell autoimmunity and to remaining beta-cell function. Hum Immunol 2009, 70:447-451.
33. Capoluongo E., Pitocco D., Concolino P., et al. Slight association between type 1 diabetes and " ff" VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. Clin Biochem 2006, 39:888-892.
34. Arai H., Miyamoto K., Taketani Y., et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J. Bone Miner Res 1997, 12:915-921.
35. Jurutka P.W., Remus L.S., Whitfield G.K., et al. The polymorphic N terminus in human Vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol 2000, 14:401-420.